Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant Cases.
Vincenzo FormicaJessica LucchettiElena DoldoSilvia RiondinoCristina MorelliRenato ArgiròNicola RenziDaniele NittiAntonella NardecchiaEmanuela Dell'AquilaPatrizia FerroniFiorella GuadagniGiampiero PalmieriAugusto OrlandiMario RoselliPublished in: Journal of clinical medicine (2020)
PL mutational analysis allows a better prognostication than T analysis alone and could help in mCRC treatment management.